Compile Data Set for Download or QSAR
Report error Found 646 Enz. Inhib. hit(s) with all data for entry = 9095
TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441060(US10640495, Example I-39 | US10640495, Example I-3...)
Affinity DataIC50: 0.480nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441096(US10640495, Example I-258)
Affinity DataIC50: 0.480nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441075(US10640495, Example I-135)
Affinity DataIC50: 0.520nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441123(US10640495, Example I-458)
Affinity DataIC50: 0.520nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441133(US10640495, Example I-639)
Affinity DataIC50: 0.520nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441097(US10640495, Example I-268)
Affinity DataIC50: 0.550nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441104(US10640495, Example I-298)
Affinity DataIC50: 0.600nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441110(US10640495, Example I-315)
Affinity DataIC50: 0.760nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441060(US10640495, Example I-39 | US10640495, Example I-3...)
Affinity DataIC50: 0.780nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441057(US10640495, Example I-22)
Affinity DataIC50: 0.810nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441077(US10640495, Example I-145)
Affinity DataIC50: 0.870nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441063(US10640495, Example I-65 | US10640495, Example I-4...)
Affinity DataIC50: 0.920nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441129(US10640495, Example I-489 | US10640495, Example I-...)
Affinity DataIC50: 0.930nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441116(US10640495, Example I-344)
Affinity DataIC50: 0.970nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441072(US10640495, Example I-108)
Affinity DataIC50: 1nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441124(US10640495, Example I-508)
Affinity DataIC50: 1.10nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441068(US10640495, Example I-73)
Affinity DataIC50: 1.20nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441111(US10640495, Example I-319)
Affinity DataIC50: 1.20nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441115(US10640495, Example I-332)
Affinity DataIC50: 1.20nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441095(US10640495, Example I-253)
Affinity DataIC50: 1.30nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441125(US10640495, Example I-323 | US10640495, Example I-...)
Affinity DataIC50: 1.30nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441061(US10640495, Example I-36)
Affinity DataIC50: 1.40nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441089(US10640495, Example I-97 | US10640495, Example I-2...)
Affinity DataIC50: 1.40nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441132(US10640495, Example I-638)
Affinity DataIC50: 1.40nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441069(US10640495, Example I-79)
Affinity DataIC50: 1.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441065(US10640495, Example I-211 | US10640495, Example I-...)
Affinity DataIC50: 1.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441088(US10640495, Example I-233)
Affinity DataIC50: 1.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441107(US10640495, Example I-303)
Affinity DataIC50: 1.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441117(US10640495, Example I-356)
Affinity DataIC50: 1.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441063(US10640495, Example I-65 | US10640495, Example I-4...)
Affinity DataIC50: 1.60nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441067(US10640495, Example I-186 | US10640495, Example I-...)
Affinity DataIC50: 1.60nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441114(US10640495, Example I-329)
Affinity DataIC50: 1.70nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441128(US10640495, Example I-552)
Affinity DataIC50: 1.70nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441101(US10640495, Example I-279)
Affinity DataIC50: 2nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441103(US10640495, Example I-291)
Affinity DataIC50: 2nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441108(US10640495, Example I-309)
Affinity DataIC50: 2nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441079(US10640495, Example I-359 | US10640495, Example I-...)
Affinity DataIC50: 2.10nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441082(US10640495, Example I-190)
Affinity DataIC50: 2.10nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441105(US10640495, Example I-299)
Affinity DataIC50: 2.10nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441065(US10640495, Example I-211 | US10640495, Example I-...)
Affinity DataIC50: 2.20nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441119(US10640495, Example I-406)
Affinity DataIC50: 2.20nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441073(US10640495, Example I-322 | US10640495, Example I-...)
Affinity DataIC50: 2.40nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441059(US10640495, Example I-28)
Affinity DataIC50: 2.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441081(US10640495, Example I-325 | US10640495, Example I-...)
Affinity DataIC50: 2.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441120(US10640495, Example I-413)
Affinity DataIC50: 2.5nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441074(US10640495, Example I-122)
Affinity DataIC50: 2.70nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441102(US10640495, Example I-361 | US10640495, Example I-...)
Affinity DataIC50: 2.70nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441058(US10640495, Example I-25)
Affinity DataIC50: 2.90nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441094(US10640495, Example I-52 | US10640495, Example I-2...)
Affinity DataIC50: 3nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shionogi

US Patent
LigandPNGBDBM441099(US10640495, Example I-275)
Affinity DataIC50: 3nMAssay Description:Seven point five μL per well of human TrkA (PV3144, Lifetechnologies, final concentration: 1 nmol/L) suspended in the assay buffer (100 mmol/L 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 646 total ) | Next | Last >>
Jump to: